NL8204978A - Nieuwe aromatische aminoalkoxyverbindingen, werkwijze voor hun bereiding en hun toepassing in de geneeskunde. - Google Patents

Nieuwe aromatische aminoalkoxyverbindingen, werkwijze voor hun bereiding en hun toepassing in de geneeskunde. Download PDF

Info

Publication number
NL8204978A
NL8204978A NL8204978A NL8204978A NL8204978A NL 8204978 A NL8204978 A NL 8204978A NL 8204978 A NL8204978 A NL 8204978A NL 8204978 A NL8204978 A NL 8204978A NL 8204978 A NL8204978 A NL 8204978A
Authority
NL
Netherlands
Prior art keywords
formula
compounds
group
chain
salts
Prior art date
Application number
NL8204978A
Other languages
English (en)
Dutch (nl)
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8124244A external-priority patent/FR2518992A1/fr
Priority claimed from FR8221053A external-priority patent/FR2537970B1/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of NL8204978A publication Critical patent/NL8204978A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Peptides Or Proteins (AREA)
NL8204978A 1981-12-24 1982-12-23 Nieuwe aromatische aminoalkoxyverbindingen, werkwijze voor hun bereiding en hun toepassing in de geneeskunde. NL8204978A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8124244 1981-12-24
FR8124244A FR2518992A1 (fr) 1981-12-24 1981-12-24 Nouveaux derives aminoalcoxy aromatiques, leur procede de preparation et leur application en therapeutique
FR8221053A FR2537970B1 (fr) 1982-12-15 1982-12-15 Nouveaux derives aminoalkoxy aromatiques, leur procede de preparation et leur application en therapeutique
FR8221053 1982-12-15

Publications (1)

Publication Number Publication Date
NL8204978A true NL8204978A (nl) 1983-07-18

Family

ID=26222677

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8204978A NL8204978A (nl) 1981-12-24 1982-12-23 Nieuwe aromatische aminoalkoxyverbindingen, werkwijze voor hun bereiding en hun toepassing in de geneeskunde.

Country Status (13)

Country Link
US (3) US4536500A (de)
JP (1) JPH04210944A (de)
AU (1) AU9193482A (de)
CA (1) CA1197243A (de)
CH (2) CH661509A5 (de)
DE (1) DE3247860A1 (de)
ES (1) ES518518A0 (de)
GB (2) GB2113680B (de)
GR (1) GR78370B (de)
IT (1) IT1191152B (de)
LU (1) LU84548A1 (de)
NL (1) NL8204978A (de)
SE (2) SE453916B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017572A (en) * 1988-04-22 1991-05-21 Delalande S.A. Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics
US5270325A (en) * 1988-07-28 1993-12-14 Basf Aktiengesellschaft P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US4937235A (en) * 1989-01-23 1990-06-26 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives
FR2646670A1 (fr) * 1989-05-05 1990-11-09 Delalande Sa Utilisation de derives aminoalkoxy aromatiques pour le traitement des troubles du systeme cerebrovasculaire
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
US5356891A (en) * 1989-09-22 1994-10-18 Witiak Donald T Phenylalkyl amine derivatives having anti-ischaemic activity
WO1991007958A1 (en) * 1989-12-06 1991-06-13 Vsesojuzny Kardiologichesky Nauchny Tsentr Pharmaceutical preparation-protector of myocardium under ischemia and reperfusion
GB9321811D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Plc Pharmaceuticals
FR2734831B1 (fr) * 1995-05-29 1997-07-11 Oreal Composition solide expansee dont la matrice est constituee d'un reseau alveolaire amidonne et contenant des particules de polyamide spheroidales calibrees et utilisations en application topique
WO1999007377A1 (en) * 1997-08-07 1999-02-18 Eli Lilly And Company 1-[4-(substituted alkoxy)benzyl]naphthalene compounds having estrogen inhibitory activity
US6054246A (en) * 1998-07-01 2000-04-25 Polaroid Corporation Heat and radiation-sensitive imaging medium, and processes for use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB377464A (en) * 1930-08-28 1932-07-28 Chem Ind Basel Manufacture of substituted aromatic ketones
GB730922A (en) * 1952-04-24 1955-06-01 Roche Products Ltd Aromatic amino-ketones and acid addition salts thereof and a process for the manufacture of same
US2668850A (en) * 1952-04-24 1954-02-09 Hoffmann La Roche Phenyl-phenethyl ketones
GB872997A (en) * 1957-01-26 1961-07-19 Pharmacia Ab Substituted ún-aminoalkoxy-acyl benzenes and processes for their manufacture
GB905903A (en) * 1960-05-25 1962-09-12 Guidotti & C Spa Labor Dialkylaminoethoxyketones having a coronary-dilating action and methods of preparingthem
US3077472A (en) * 1961-03-21 1963-02-12 Univ Kansas Res Foundation 3-[4-(aminoalkoxy)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
GB1063744A (en) * 1964-05-25 1967-03-30 American Cyanamid Co 4-substituted-4'-tertiary aminoalkoxy biphenyls
GB1111336A (en) * 1964-07-24 1968-04-24 Fisons Pharmaceuticals Ltd Aryl ketones
FR5733M (de) * 1966-09-27 1968-01-22
GB1388088A (en) * 1973-05-16 1975-03-19 Inst Med Parazitologii I Tropi N-b-2-acetyl-4-chloro-phenoxy-ethyl-n,n-dimethyl-n-benzyl- ammonium-p-chlorobenzene sulphonate method for preparing same and medicinal preparation based thereon

Also Published As

Publication number Publication date
SE8505219L (sv) 1985-11-06
US4831051A (en) 1989-05-16
IT8224964A0 (it) 1982-12-23
LU84548A1 (fr) 1984-10-22
SE8207224D0 (sv) 1982-12-17
ES8308864A1 (es) 1983-10-01
JPH04210944A (ja) 1992-08-03
CH661509A5 (fr) 1987-07-31
GB2113680B (en) 1986-08-13
SE453916B (sv) 1988-03-14
SE8505219D0 (sv) 1985-11-06
CH655313A5 (fr) 1986-04-15
DE3247860C2 (de) 1993-08-05
IT1191152B (it) 1988-02-24
GB2154587A (en) 1985-09-11
GB8506732D0 (en) 1985-04-17
GR78370B (de) 1984-09-26
CA1197243A (en) 1985-11-26
DE3247860A1 (de) 1983-07-28
GB2154587B (en) 1986-08-20
US4732896A (en) 1988-03-22
SE8207224L (sv) 1983-06-25
GB2113680A (en) 1983-08-10
AU9193482A (en) 1983-09-01
US4536500A (en) 1985-08-20
ES518518A0 (es) 1983-10-01

Similar Documents

Publication Publication Date Title
NL8204978A (nl) Nieuwe aromatische aminoalkoxyverbindingen, werkwijze voor hun bereiding en hun toepassing in de geneeskunde.
Yahara et al. Isolation and characterization of phenolic compounds from magnoliae cortex produced in China
De Paulis et al. Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides
Patra et al. Constituents of Acorus calamus: structure of acoramone. Carbon-13 NMR spectra of cis-and trans-asarone
DE69220037T2 (de) Acridinderivate
CZ110994A3 (en) Indane and indene derivatives, process of their preparation and pharmaceutical composition containing thereof
Furukawa et al. New carbazolequinones having dimethylpyran ring system, from Murraya euchrestifolia
Rukachaisirikul et al. Xanthones from the stem bark of Garcinia nigrolineata
Ogura et al. Total synthesis of acerogenins E, G and K, and centrolobol
Gómez-Ayala et al. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives
Bringmann et al. 5′-O-demethyldioncophylline A, a new antimalarial alkaloid from Triphyophyllum peltatum
Liu et al. Regioselective Synthesis of Aurone Derivatives via PBu3‐Catalyzed Cyclization of 2‐Alkynoylphenols
Shen et al. Synthesis and biological evaluation of resveratrol–coumarin hybrid compounds as potential antitumor agents
Inatani et al. Structure and Synthesis of New Phenolic Amides from Piper nigrum L.
EP0359290B1 (de) Aromatische Diole
Hampton et al. Twofold Terminal Alkylations of Disodio β-Diketones with Methylene Halides to Form Bis-β-diketones1
Mazimba et al. Synthesis and antibacterial activities of cyclodimers of styrene oxides
Kozuka Synthesis of dihydrobenzofuran derivatives from substituted p-benzoquinones.
SE457255B (sv) 3-aminoproxifenylderivat, deras framstaellning och laekemedel innehaallande dessa
Ahmed et al. Intramolecular aminolysis of 2′-aminochalcone epoxides using InBr3 or BiCl3 as efficient catalysts
Diao et al. Benzofuran–isatin Hybrids: Design, Synthesis, and In Vitro Anti‐cancer Activities
Akita et al. Coupling reactions of aryl and heteroaryl halides with a trimethylsilylethynylpyrazine
Akbari et al. A New Method for the Synthesis of 1-Methyl-1H-indole-3-carboxylate Derivatives, Employing Copper (II)
Costa et al. Eugenol and safrole as starting materials for the synthesis of 3-alkyl muconic acid mono and dimethyl esters and 4, 4-dialkyl butenolides
US4059593A (en) Synthesis of steganacin and derivatives thereof

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed